Biomere Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 142

Employees

  • Latest Deal Type
  • Angel

  • Investors
  • 1

Biomere General Information

Description

Provider of preclinical research services intended to support drug development activities through comprehensive nonclinical studies. The company provides preclinical efficacy assessments, pharmacokinetic and pharmacodynamic studies, absorption, distribution, metabolism, and excretion studies, model availability, vivarium facilities, laboratory support, non-Good Laboratory Practice (GLP) and Good Laboratory Practice (GLP) study execution, and project resourcing, enabling clients to conduct regulated and non-regulated drug development studies.

Contact Information

Website
www.biomere.com
Formerly Known As
Biomedical Research Models
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Angel-Backed
Corporate Office
  • 57 Union Street
  • Worcester, MA 01608
  • United States
+1 (508)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Laboratory Services (Healthcare)
Other Healthcare Services
Parent Company
Vertical(s)
Corporate Office
  • 57 Union Street
  • Worcester, MA 01608
  • United States
+1 (508)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomere Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Angel (individual) 01-Sep-2021 Completed Generating Revenue
7. Debt - PPP 13-Apr-2020 Completed Generating Revenue
6. Merger/Acquisition 10-Dec-2019 Completed Generating Revenue
5. Grant 01-Jan-2014 Completed Generating Revenue
4. Angel (individual) 22-Jan-2007 Completed Generating Revenue
3. Angel (individual) 29-Dec-2004 Completed Generating Revenue
2. Grant $25M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Biomere’s complete valuation and funding history, request access »

Biomere Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of preclinical research services intended to support drug development activities through comprehensive nonclini
Other Pharmaceuticals and Biotechnology
Worcester, MA
142 As of 2025

Shanghai, China

Rensselaer, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biomere Competitors (8)

One of Biomere’s 8 competitors is Medkey, a Private Equity-Backed company based in Shanghai, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medkey Private Equity-Backed Shanghai, China
Taconic Biosciences Private Equity-Backed Rensselaer, NY
Parexel International Private Equity-Backed Raleigh, NC
Veristat Private Equity-Backed Southborough, MA
CTI Clinical Trial and Consulting Private Equity-Backed Covington, KY
You’re viewing 5 of 8 competitors. Get the full list »

Biomere Patents

Biomere Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014203873-A1 Therapeutic vaccines for treating herpes simplex virus type 2 infections Inactive 07-Jan-2013
WO-2014107731-A1 Therapeutic vaccines for treating herpes simplex virus type 2 infections Inactive 07-Jan-2013
JP-2018131461-A Therapeutic vaccines for treating herpes simplex virus type-2 infections Active 07-Jan-2013
ES-2651005-T3 A new mucosal vaccination strategy for herpes simplex virus type-2 Active 09-Mar-2010
EP-2544693-A1 A novel mucosal vaccination approach for herpes simplex virus type-2 Active 09-Mar-2010 A61K39/245
To view Biomere’s complete patent history, request access »

Biomere Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomere Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Massachusetts Biomedical Initiatives Accelerator/Incubator
National Center for Research Resources Government
National Heart, Lung, and Blood Institute Government
National Institute for Allergy and Infectious Disease Government
National Institute of Diabetes and Digestive and Kidney Diseases Government
You’re viewing 5 of 8 investors. Get the full list »

Biomere FAQs

  • When was Biomere founded?

    Biomere was founded in 1996.

  • Where is Biomere headquartered?

    Biomere is headquartered in Worcester, MA.

  • What is the size of Biomere?

    Biomere has 142 total employees.

  • What industry is Biomere in?

    Biomere’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Biomere a private or public company?

    Biomere is a Private company.

  • What is Biomere’s current revenue?

    The current revenue for Biomere is .

  • How much funding has Biomere raised over time?

    Biomere has raised $320K.

  • Who are Biomere’s investors?

    Massachusetts Biomedical Initiatives, National Center for Research Resources, National Heart, Lung, and Blood Institute, National Institute for Allergy and Infectious Disease, and National Institute of Diabetes and Digestive and Kidney Diseases are 5 of 8 investors who have invested in Biomere.

  • Who are Biomere’s competitors?

    Medkey, Taconic Biosciences, Parexel International, Veristat, and CTI Clinical Trial and Consulting are some of the 8 competitors of Biomere.

  • When was Biomere acquired?

    Biomere was acquired on 01-Sep-2021.

  • Who acquired Biomere?

    Biomere was acquired by Joinn Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process